CCL26 as a prognostic biomarker in hepatocellular carcinoma: integrating bioinformatics analysis, clinical validation, and radiomics score
CCL26 serves as a significant prognostic biomarker in HCC. The developed Rad-score provides an effective, non-invasive tool for predicting patient outcomes and enhancing clinical decision-making. This study not only highlights the prognostic role of CCL26 but also offers a novel approach for evaluating HCC patient prognosis through radiomics.
Authors
- Sihai Chen (ORCID: https://orcid.org/0000-0002-0640-5936)
- Yong Xie (ORCID: https://orcid.org/0000-0002-6589-7854)
- Junjun Yan
- Qiangming Liao
Institutions
- First Affiliated Hospital of Jiangxi Medical College (CN)
- Jiujiang First People's Hospital (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-04-09
- DOI
- https://doi.org/10.1007/s12672-025-02280-1
- Citations
- 1
- Primary Topic
- Radiomics and Machine Learning in Medical Imaging
- Type
- article
- Field-Weighted Citation Impact
- 1.36